Document Detail


Regression of structural vascular changes in hypertensives after captopril treatment.
MedLine Citation:
PMID:  1505564     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
In order to investigate whether hypertension-related structural vascular changes may be influenced by antihypertensive treatment, 10 patients were studied suffering from essential arterial hypertension, five males and five females, aged between 34 and 61 years (mean age: 46.9 +/- 8.13 years). All patients received a placebo for 1 week and then captopril, 75 mg b.i.d. for 3 months. After placebo and captopril treatments, the following parameters were evaluated: SBP, DBP, mean blood pressure (MBP), by the formula 1/3 (SBP + 2 x DBP) and basal and minimal vascular resistances, respectively obtained by the ratios MBP/rest flow and MBP/peak flow. Blood flows have been obtained by strain gauge plethysmography. A significant decrease in systolic (P less than 0.025), diastolic (P less than 0.01) and mean blood pressure (P less than 0.01), basal vascular resistances (52 +/- 19 vs 28 +/- 12 A.U., P less than 0.01) and minimal vascular resistances (6.3 +/- 2.2 vs 3.9 +/- 2.8 A.U., P less than 0.025) has been observed after captopril treatment in comparison to placebo, whereas rest (2.9 +/- 0.7 vs 4.1 +/- 0.9 ml.min-1.100 g-1, P less than 0.01) and peak blood flows (21.3 +/- 5.8 vs 29.7 +/- 9.4 ml.min-1.100 g-1) significantly increased. These data seem to indicate that antihypertensive treatment with the angiotensin-converting enzyme inhibitor, captopril, is not only efficacious in inducing a significant blood pressure decrease, consequent to the reduction of basal vascular resistance (due to the vasodilating effects of the drug), but is also able to reduce minimal vascular resistance.(ABSTRACT TRUNCATED AT 250 WORDS)
Authors:
S Novo; M G Abrignani; A Pinto; A Strano
Related Documents :
1395074 - An indirect evaluation of the effect of the autonomic nervous system following converti...
1606744 - Cardiac effects of local angiotensin-converting enzyme inhibition in hypertensive patie...
1812274 - Pharmacology of a phosphorus-containing novel angiotensin converting enzyme inhibitor, ...
9759984 - Captopril, but not nifedipine, improves endothelium-dependent vasodilation in hypertens...
16171604 - Pressure elevation slows the fibroblast response to wound healing.
1354084 - A comparison of guanfacine, bunazosin, atenolol and nadolol on blood pressure and plasm...
Publication Detail:
Type:  Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  European heart journal     Volume:  13     ISSN:  0195-668X     ISO Abbreviation:  Eur. Heart J.     Publication Date:  1992 Aug 
Date Detail:
Created Date:  1992-09-23     Completed Date:  1992-09-23     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  8006263     Medline TA:  Eur Heart J     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  1135-7     Citation Subset:  IM    
Affiliation:
Chair of Clinical Pathophysiology, University of Catania, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Blood Flow Velocity / drug effects,  physiology
Blood Pressure / drug effects,  physiology
Captopril / therapeutic use*
Female
Hemodynamics / drug effects*,  physiology
Humans
Hypertension / drug therapy*,  physiopathology
Leg / blood supply
Middle Aged
Muscle, Smooth, Vascular / drug effects*,  physiopathology
Plethysmography
Vascular Resistance / drug effects,  physiology
Chemical
Reg. No./Substance:
62571-86-2/Captopril

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of benazepril on myocardial ischaemia in patients with chronic stable angina pectoris.
Next Document:  Clinical significance of silent ischaemia and implications for treatment: role of radionuclide techn...